Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma

Journal of the Pakistan Medical Association

Volumn 62, Issue 1, 2012, Pages

  Abbasi, Amanullah ^a   Bhutto, Abdul Rabb ^a   Butt, Nazish ^a   Munir, Syed Mohammad ^a  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

Alpha feto protein; Chronic liver disease; Hepatocellular carcinoma

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; GLOBULIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; SERUM ALBUMIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER DIAGNOSIS; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; TUMOR VOLUME; ABDOMEN; BIOPSY; BLOOD; HEPATITIS B; HEPATITIS C; LIVER; LIVER CIRRHOSIS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOPSY; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84455194779     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009; 44: 96-101.
2. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-22.
3. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 817-23.
4. Aguayo A, Patt YZ. Liver cancer. Clin Liver Dis 2001; 5: 479-507.
5. Abdul Mujeeb S, Jamal Q, Khanani R, Iqbal N, Kaher S. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan. Trop Doct 1997; 27: 45-6.
6. Kubo Y, Okuda K, Musha H, Nakashima T. Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observation in 31 patients. Gastroenterology 1978; 74: 578-82.
7. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-7.
8. Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography: a study in 51 patients. Gastroenterology 1984; 86: 495-502.
9. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and nonfucosylated triantennary glycans. Br J Cancer 1993; 67: 486-92.
10. Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv 2003; 58: 804-26.
11. Sharieff S, Burney I, Salam A, Siddiqui T. Lack of correlation between aipha-fetoprotein and tumor size in hepatocellular carcinoma. J Pak Med Assoc 2001; 51: 123-4.
12. Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultra sonography screening for hepatoculular carcinoma. Gastroenterol 2004; 127: S108-12.
13. Khokhar N, Aijazi I, Gill ML. Spectrum of hepatocellular carcinoma at Shifa International Hospital, Islamabad. J Ayub Med Coll Abbottabad 2003; 15: 1-4.
14. Leung TW, Tang AM, Zee B, Lau WY, Lai PB, Leung KL, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002; 94: 1760-9.
15. Nabulsi MM, El-Saleeby CM, Araj GF. Lebanese Hepatitis B Collaborative Study Group. The current status of hepatitis B in Lebanon. J Med Leban 2003; 51: 64-70.
16. Bruix J, Sherman M; Practice Guideline. Committee American Association for the study of liver diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
17. Harada T, Shigeta K, Noda K, Fukumoto Y, Nishimura H, Mizuta M, et al. Clinical implications of slpha-fetoprotein in liver cirrhosis: five-year follow-up study. Hepatogastroenterol 1980; 27: 169-75.
18. Rodriguez-Diaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, et al. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Clin Oncol (R Coll Radiol) 2007; 19: 197-203.
19. Arrieta O, Rodríguez-Díaz J, Rosas-Camargo V, Morales-Espinosa D, Ponce de León S, Kershenobich D, et al. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus related-liver cirrhosis. Cancer 2006; 107: 1852-8.
20. Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 2004; 127: S104-7.
21. Sherman M. Alpha fetoprotein: an obituary. J Hepatol 2001; 34: 603-5.
22. Chen DS, Sung JL. Hepatitis B virus infection in Taiwan. N Engl J Med 1977; 297: 668-9.
23. Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, et al. [Hepatocellular carcinoma in Germany. Epidemiology, aetiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Z Gastroenterol 1997; 35: 1059-67.
24. Kapoor D, Aggarwal SR, Singh NP, Thakur V, Sarin SK. Granulocyte-macrophage colonystimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepatol 1999; 6: 405-9.
25. Francioni S, Pastore M. Alpha-fetoprotein and acute viral hepatitis type B. J Nucl Med Allied Sci 1989; 33: 103-6.
26. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125: 89-97.